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often given with prednisolone, would 
have been necessary.
In pregnant women with West 
African (T. brucei gambiense) stage 
II disease, either melarsoprol or ef-
lornithine can be used, but neither 
is effective for East African disease. 
Although eﬂ  ornithine can abort early 
pregnancies and cause disordered or-
ganogenesis (9), the severe enceph-
alopathy associated with melarsoprol 
makes eﬂ  ornithine a preferable option 
for single-agent treatment. However, 
nifurtimox–eﬂ  ornithine  combination 
therapy will soon replace single-drug 
regimens for stage II T. brucei gambi-
ense cases (10).
We believed evidence was insuf-
ﬁ  cient to withhold suramin therapy for 
this highly fatal disease. Because of 
the uncertainty about effects of preg-
nancy on the ability to clear trypano-
somes, the patient will be followed 
up for signs of relapse. The danger of 
HAT should be speciﬁ  cally highlight-
ed for all travelers to trypanasomiasis-
endemic regions, particularly pregnant 
travelers because of potential harm to 
unborn children.
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Rickettsia africae 
Infection in Man 
after Travel to 
Ethiopia
To the Editor: The ﬁ  rst human 
case of African tick-bite fever was de-
scribed in 1992 as occurring in Zimba-
bwe. The causative agent was identi-
ﬁ  ed as a new serotype of the spotted 
fever group (SFG) rickettsiae and 
named  Rickettsia africae ( 1). These 
ﬁ  ndings conﬁ  rmed observations made 
by Pijper in the 1930s which suggest-
ed that there were 2 different kinds of 
human SFG rickettsioses in sub-Sa-
haran Africa: Mediterranean spotted 
fever caused by R. conorii and trans-
mitted by Rhipicephalus species, ticks 
of dogs, and African tick-bite fever 
caused by R. africae and transmitted 
by Amblyomma species, ticks of cattle 
and wild ungulates. African tick-bite 
fever has subsequently been diag-
nosed in patients from several other 
sub-Saharan countries and also from 
the West Indies (2,3).
In a recent analysis of the spec-
trum of diseases among returning trav-
elers, tick-borne spotted fever was (af-
ter malaria) the second most frequent 
cause of systemic febrile illness among 
those returning from sub-Saharan Af-
rica. It occurred more frequently than 
typhoid fever and dengue fever (4). 
The following case description reports 
an infection with R. africae in a man 
in France who recently returned from 
Ethiopia. 
On November 4, 2005, a 62-year-
old French man sought care at the 
Medical Center of the Institut Pasteur 
in Paris for fever, along with chills, 
headache, neck and shoulder pain, 
and fatigue over the previous 4 days. 
At the onset of these symptoms he 
had noticed dark nodular lesions on 
his neck and his left groin followed 2 
days later by a slightly painful erup-
tion on his arms and his trunk. He had 
spent a month in southwest Ethiopia, 
north of Kelem near the Sudanese bor-
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der, and returned to France on October 
26, 2005. While in Ethiopia, he had 
assisted with a production of a docu-
mentary ﬁ  lm about an Ethiopian tribe 
and had been in contact with cattle in 
the villages. He had not noticed any 
tick bites. On physical examination he 
had a fever of 38°C, a nodular lesion 
with a central dark crust on his neck, a 
second lesion on his left inguinal fold 
(Figure, panel A), and a vesicular erup-
tion on his arms and his trunk (Figure, 
panel B). Leukocyte count was 3,200, 
including 1,869 neutrophils and 867 
lymphocytes. The platelet level was 
174,000/mm3. The C-reactive protein 
level was 28.3 mg/L. The aspartate 
aminotransferase level was slightly 
elevated. The patient was treated with 
doxycycline 200 mg/day for 1 week 
for suspected African tick-bite fever. 
Follow-up showed a quick recovery 
from his symptoms except for fatigue 
that persisted for ≈1 month. 
A commercial immunoﬂ  uores-
cence assay for R. conorii and R. typhi 
immunoglobulin G performed both 
on an initial blood sample and a sec-
ond sample taken 1 week later were 
negative. A blood sample and a bi-
opsy specimen of the inguinal eschar 
were sent to the National Reference 
Center of Rickettsiae in Marseille, 
France. Although cellular culture of 
both specimens and molecular test-
ing of the blood sample were nega-
tive, PCR for the sequences of citrate 
synthase (GenBank accession no. 
RAU59733, 93.1% homology) and 
rickettsial OmpA (GenBank accession 
no. RAU83436, 99.3% homology) ap-
plied on the skin biopsy detected R. 
africae and conﬁ  rmed the diagnosis of 
African tick-bite fever.
From 1969 to 1971, SFG rick-
ettsiae were isolated from Amblyom-
ma spp. ticks collected in Ethiopia. 
They were regarded as R. conorii or 
as closely related bacteria (5). Later, 
more speciﬁ  c tests using western im-
munoblots with monoclonal antibod-
ies showed that these rickettsiae dif-
fered from R. conorii (6). In 1992 SFG 
rickettsiae isolated from Amblyomma 
ticks collected in Zimbabwe and from 
the blood of a patient in Zimbabwe 
were compared to R. conorii, to other 
pathogenic SFG rickettsiae, and to a 
SFG rickettsia isolated from an Am-
blyomma spp. tick in Ethiopia 20 years 
before. The SFG rickettsia isolates 
from Ethiopia were identical to isolates 
obtained in Zimbabwe from the Am-
blyomma ticks and the patient’s blood 
and were different from R. conorii and 
other pathogenic SFG rickettsiae. This 
new serotype of SFG rickettsiae was 
named R. africae (1,7). A recent study 
conﬁ  rmed the presence of R. africae in 
ticks collected in Ethiopia, as well as 
R. aeschlimanii (8). Thus, evidence of 
R. africae in Ethiopia has been known 
for a long time. 
The geographic distribution of 
African tick-bite fever is related to the 
presence of Amblyomma spp. ticks, 
vectors and reservoirs of R. africae. 
Consequently African tick-bite fever 
should also be considered as a pos-
sible diagnosis in patients with febrile 
illness returning from countries where 
R. africae has been detected in Ambly-
omma ticks, even if a human infection 
has not yet been reported (9,10).
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Figure. Inoculation eschar on left inguinal fold (A) and vesicular skin lesion (B) in a traveler 
recently returned to France from Ethiopia.LETTERS
Dorothea Stephany, 
Pierre Buffet, Jean-Marc Rolain, 
Didier Raoult, 
and Paul H. Consigny
Author afﬁ   liations: Institut Pasteur, Paris, 
France (D. Stephany, P. Buffet, P.H. Con-
signy); and Université de la Méditerranée, 
Marseille, France (J.M. Rolain, D. Raoult).
DOI: 10.3201/eid1511.090521
References
    1.   Kelly PJ, Beati L, Matthewman LA, 
Mason PR, Dasch GA, Raoult D. A new 
pathogenic spotted fever group rick-
ettsia from Africa. J Trop Med Hyg. 
1994;97:129–37.
  2.   Raoult D, Fournier PE, Fenollar F, Jense-
nius M, Prioe T, de Pina JJ, et al. Rick-
ettsia africae, a tick-borne pathogen in 
travelers to sub-Saharan Africa. N Engl J 
Med. 2001;344:1504–10. DOI: 10.1056/
NEJM200105173442003
  3.   Ndip LM, Bouyer DH, Travassos Da Rosa 
AP, Titanji VP, Tesh RB, Walker DH. 
Acute spotted fever rickettsiosis among 
febrile patients, Cameroon. Emerg Infect 
Dis. 2004;10:432–7.
    4.    Freedman DO, Weld LH, Kozarsky PE, 
Fisk T, Robins R, von Sonnenburg F, et al. 
Spectrum of disease and relation to place 
of exposure among ill returned travelers. 
N Engl J Med. 2006;354:119–30. DOI: 
10.1056/NEJMoa051331
  5.   Burgdorfer W, Ormsbee RA, Schmidt ML, 
Hoogstraal H. A search for the epidemic 
typhus agent in Ethiopian ticks. Bull 
World Health Organ. 1973;48:563–9.
  6.   Walker DH, Liu QH, Yu XJ, Li H, Tay-
lor C, Fenq HM. Antigenic diversity of 
Rickettsia conorii. Am J Trop Med Hyg. 
1992;47:78–86.
  7.   Kelly PJ, Matthewman LA, Beati L, Raoult 
D, Mason P, Dreary M, et al. African tick 
bite fever: a new spotted fever group un-
der an old name. Lancet. 1992;340:982–3.   
Medline  DOI: 10.1016/0140-6736(92)
92878-J 
  8.   Mura A, Socolovschi C, Ginesta J, Lafrance 
B, Magnan S, Rolain JM, et al. Molecular 
detection of spotted fever group rickettsiae 
in ticks from Ethiopia and Chad. Trans 
R Soc Trop Med Hyg. 2008;102:945–9. 
DOI: 10.1016/j.trstmh.2008.03.015
  9.   Parola P, Raoult D. Ticks and tickborne 
bacterial diseases in humans: an emerg-
ing infectious threat. Clin Infect Dis. 
2001;32:897–928. DOI: 10.1086/319347
10.   Parola P, Barre N. Rickettsia africae, 
agent de la ﬁ   èvre à tique africaine: un 
pathogène émergent dans les Antilles et 
l'île de la Réunion. Bull Soc Pathol Exot. 
2004;97:193–8.
Address for correspondence: Paul H. Consigny, 
Centre Médical, Institut Pasteur, 28, rue du 
Docteur Roux, 75724 Paris Cedex 15, France; 
email: consigny@pasteur.fr
Rickettsia 
massiliae in the 
Canary Islands
To the Editor: Rickettsia massil-
iae was recently recognized as a hu-
man tick-borne spotted fever group 
rickettsia (1). We report the ﬁ  nding of 
R. massiliae in Rhipicephalus pusillus 
ticks from Gran Canaria, Canary Is-
lands, Spain. Introduction of this patho-
gen into the Canary Islands is thought 
to have resulted from translocation of 
the European wild rabbit Oryctola-
gus cuniculus (Linnaeus), a preferred 
host of R. pusillus ticks (www.kolonin.
org/16_4.html), from the Iberian Pen-
insula 600 years ago (2).
We collected questing adult ticks 
in 2008 in Gran Canaria and identiﬁ  ed 
2 tick species, Hyalomma lusitanicum 
(n = 82 [46 females]) and R. pusil-
lus (n = 8 [5 females]). Whole ticks 
were preserved in 70% ethanol and 
used for DNA extraction by using 
TriReagent (Sigma, St. Louis, MO, 
USA) according to the manufacturer’s 
instructions. We identiﬁ  ed  rickett-
sial sequences by using PCR primers 
that amplify fragments of 16S rRNA, 
ompB, atpA, dnaA, dnaK, and recA 
genes (Table). Amplicons were cloned 
into pGEM-T (Promega, Madison, 
WI, USA), and 3 independent clones 
were sequenced from both ends for 
each gene marker. Sequence similar-
ity search was performed by using 
BLAST (www.ncbi.nlm.nih.gov). 
Rickettsial DNA was detected in 2 R. 
pusillus males only; sequences were 
identical in both ticks. Fragments of 
16S rRNA were 99% identical to the 
R. massiliae strain Mtu5 (CP000683) 
isolated from R. sanguineus ticks in 
southern France (3), and fragments 
of ompB, atpA, dnaA, dnaK, and recA 
genes were 100% identical to the R. 
massiliae strain Bar29 (AF123710, 
AY124739, DQ821798, DQ821828, 
and AY124750, respectively), previ-
ously isolated from R. sanguineus 
ticks in Catalonia, Spain (4) (Table).
R. massiliae was ﬁ  rst isolated in 
1992 from R. sanguineus ticks col-
lected near Marseille, France (5). 
Since then, the pathogen has been 
identiﬁ   ed in different Rhipicephalus 
species in France, Greece, Portugal, 
Switzerland, Spain, North and Cen-
tral Africa, Argentina, and the United 
States (6,7).  R. massiliae has been 
identiﬁ   ed in southern Spain (8) but 
not in the Canary Islands. R. pusillus 
ticks are commonly found in southern 
Europe (Portugal, Spain, and France) 
and northern Africa (Tunisia and Mo-
rocco). All stages of these ticks inhabit 
burrows of wild rabbits and feed on 
them (www.kolonin.org/16_4.html).
Wild rabbits were introduced into 
the Canary Islands at the end of 14th 
century during colonization by the 
kingdom of Castilla. Colonists were 
asked to bring rabbit couples with 
them to provide food in the islands (2), 
a practice continued by new colonists 
because of their interest in hunting this 
rabbit species. Introduction of wild rab-
bits by colonists led to establishment of 
parasites, such as helminths, coccidia, 
and viruses in the Canary Islands (9). 
R. pusillus, a common ectoparasite 
(tick) that feeds on wild rabbits on the 
Iberian Peninsula, was also introduced 
this way. R. massiliae could have been 
introduced in the islands by infected R. 
pusillus ticks or by infected wild rab-
bits if this species serves as a natural 
reservoir host for the pathogen.
To ﬁ  nd evidence for this hypoth-
esis, we tested blood and liver samples 
of 150 wild rabbits from both Canary 
Islands and Andalucía (southern Spain) 
by using Rickettsia-speciﬁ  c PCR prim-
ers (Table). No R. massiliae DNA was 
detected in the rabbit samples tested, 
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